• Police seek suspects in deadly birthday party shooting
  • Lawmakers launch inquires into U.S. boat strike
  • Nov. 29, 2025, 10:07 PM EST / Updated Nov. 30, 2025,…
  • Mark Kelly says troops ‘can tell’ what orders…

Be that!

contact@bethat.ne.com

 

Be That ! Menu   ≡ ╳
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics Politics
☰

Be that!

Graham Potter: Premier League breaks record for most sackings in a single season

admin - Latest News - September 22, 2025
admin
41 views 5 mins 0 Comments




CNN
 — 

It was just six months ago that Graham Potter was deemed the man to usher in a fresh, exciting era at Chelsea.

The club’s new ownership group, led by American businessman Todd Boehly, had enticed Potter away from Brighton with the promise of managing one of the most lucrative teams in world soccer.

More than $600 million was spent on bringing big-name players to the club and Potter, one of the most exciting young managers in the Premier League, was to mold them into a winning machine.

But, on Sunday, the club announced that it had sacked its manager after an underwhelming spell in charge.

Potter managed to win just 10 of the 28 league matches this season and leaves the team 11th in the Premier League table.

In recent weeks, players had looked a shadow of their former selves and many fans had lost confidence that Potter’s plan for the club could ever work.

Eventually, after previously sticking by its manager, Blues ownership agreed.

“On behalf of everyone at the club, we want to thank Graham sincerely for his contribution to Chelsea,” the club’s co-owners Todd Boehly and Behdad Eghbali said in a statement.

“We have the highest degree of respect for Graham as a coach and as a person. He has always conducted himself with professionalism and integrity and we are all disappointed in this outcome.”

Chelsea's position in the league has nosedived in recent weeks.

In his previous role as Brighton manager, Potter was given time to stamp his identity on the squad.

The club was punching above its weight financially and, as a result, carefully selected new signings which would compliment Potter’s style of play.

The approach paid off as the team became an established Premier League outfit which has gone on to greater things this season – the Seagulls currently sit sixth in the league and in the UEFA Conference League qualification spot.

At Chelsea, it seemed the complete opposite.

As was the case under previous owner Roman Abramovich, the club expected instant results and used its financial weight to sign a number of high-profile names, including the likes of Enzo Fernández and Mykhailo Mudryk.

Despite his impressive CV, Potter had never managed superstars and suddenly found himself in a changing room with multiple.

The scatter gun approach to recruitment also left the team lacking balance and organization with Potter failing to get a tune out of a team busting with talent.

In truth, many had raised an eyebrow when Potter, inexperienced at the very top level, was chosen to replace Thomas Tuchel as manager.

Despite falling out of favor with fans by the end of his tenure, Tuchel had guided Chelsea to the Champions League title in 2021 and is still considered by many as one of the best coaches in the world.

The German has gone on to sign with Bavarian giant Bayern Munich through the 2024/25 season and recently told reporters he needed “quite a bit of time to distance himself from Chelsea” because leaving the club had hurt him.

“Todd [Boehly] said he would be different to Roman [Abramovich],” former Liverpool player and current pundit Jamie Carragher wrote on Twitter.

“I feel for Graham Potter, but it was inevitable. You don’t change Tuchel for Potter. Ridiculous decision to start with.”

With 10 games left in the league and a Champions League quarterfinal against Real Madrid on the horizon, Chelsea still has plenty to play for.

Assistant coach Bruno Saltor will take over on an interim basis, but Boehly and his team must now look for a long-term replacement capable – and willing – to bring order to Chelsea’s chaos.

Potter’s sacking is yet another sign of just how transient managers can be in the top-flight of English football, especially when results aren’t instantaneous.

There has now been a record 12 sackings in the Premier League so far this season, with Potter leaving his position the same day Leicester boss Brendan Rodgers was sacked from his.

The previous record was 10 manager changes in a single season, set in four other campaigns, most recently in 2017/18.





Source link

TAGS:
PREVIOUS
Erdogan’s political fate may be determined by Turkey’s Kurds
NEXT
Wall Street Journal reporter Evan Gershkovich appeals against arrest, Russian state media says
Related Post
October 26, 2025
Trump dances after arriving in Malaysia
September 21, 2025
‘Love Is Blind’ alum sues Netflix, show producers
November 8, 2025
Savewith a NBCUniversal ProfileCreate your free profile or log in to save this articleNov. 8, 2025, 5:00 AM ESTBy Mithil AggarwalNEW DELHI — When the weight loss drug Mounjaro came on the market in India earlier this year, Shyamanthak Kiran was one of the first patients to try it.Kiran, a 27-year-old financial trader who has struggled with hypothyroidism, said he “did not have a lot of expectations” when it came to losing weight. But “luck turned out in my favor,” he said, and in six months he lost all of the 60-plus pounds he had gained a few years earlier.“It was a two-year struggle that came to an end, and I couldn’t be happier,” he told NBC News.Indians trying to lose weight are embracing drugs such as Mounjaro, which is also used to treat diabetes in a country that has been called the world’s diabetes capital. The injectable medication from American pharmaceutical company Eli Lilly has become India’s most popular drug by value since being approved in March, with over $11 million in sales in October, pharmaceutical market research firm Pharmarack said Friday.Mounjaro is an injectable medication used to treat diabetes. Saumya Khandelwal for NBC NewsEven before India’s more recent approval of Ozempic, another drug that is widely used for weight loss in the United States and other countries, there was already surging demand in the country for semaglutide, its active ingredient.Ozempic’s Danish drugmaker, Novo Nordisk, says it is “actively working” to widen the availability of the drug, which Indian regulators have approved for diabetes but not obesity. The company also makes other semaglutide drugs that are already used for weight loss in India, including Wegovy, an injectable, and Rybelsus, which is taken orally.Demand could grow even further when the patent for Ozempic’s active ingredient, semaglutide, expires next March in India, a pharmaceutical manufacturing giant where companies are eager to produce cheaper generic versions of the lucrative weight-loss drugs.The exploding popularity of the drugs has taken aback some doctors and officials, with Jitendra Singh, a government minister and physician, warning in August against the “unchecked spread of disinformation” through “fad regimens” and emphasizing the importance of lifestyle interventions such as regular yoga practice.Semaglutide and tirzepatide, the active ingredient in Mounjaro, are GLP-1 agonists that were first developed to treat diabetes and have also been approved in many countries for the treatment of obesity. They regulate blood sugar and help slow how quickly food passes through the stomach, curbing hunger as a result.India, the world’s most populous country, has over 100 million people with diabetes, or nearly 10% of its adult population, according to a 2023 study by the Indian Council of Medical Research. An additional 135 million people are prediabetic, the study found.Diabetes information displayed on the walls of a clinic in New Delhi last month.Saumya Khandelwal for NBC NewsDoctors say the situation is worsening as India’s burgeoning middle class adopts a more Western lifestyle, eating more high-fat, high-sugar foods and exercising less.“Compared to, say, a decade ago, there are more people now in their late 20s and early 30s who are being diagnosed with diabetes, as compared to the elderly population,” said Dr. Saurav Shishir Agrawal, an endocrinologist in Noida, which is part of Delhi’s capital region.“They ask us to just give them pills,” Agrawal said, “but these medicines work better only when you are clubbing them with lifestyle changes.”Agrawal practices at the newly built Medanta Hospital, where staff greet patients with a gentle “Namaste.” It is an example of the growing number of modern and high-end hospitals popping up around increasingly dense megacities such as Delhi, home to 33 million people, where diabetes has a greater hold.Saurav Agrawal, an endocrinologist at Medanta Hospital in Noida, India.Saumya Khandelwal for NBC NewsA monthly course of Mounjaro can cost as much as $250, the average monthly salary in many parts of India. But for more affluent Indians, a bigger deterrent is the idea of injecting themselves, said Dr. Tribhuvan Gulati, an endocrinologist.“People get scared whenever you tell them that they’re going to be on an injectable,” said Gulati, who has a clinic in central Delhi.Gulati keeps a demo pen of Mounjaro in a drawer to show how easy it is to use the medicine, which just needs to be refrigerated before use.But the ease of use is also what worries Gulati and other doctors, who say many patients fail to overhaul the lifestyle and dietary habits causing or contributing to their health issues in the first place.“If you look at the causes of obesity in India, it is 90% lifestyle and 10% anything else,” said Dr. Anoop Misra, chairman of the Fortis Centre for Diabetes, Obesity and Cholesterol and head of India’s National Diabetes Obesity and Cholesterol Foundation.“The diet now is totally imbalanced because of free availability of food everywhere,” he said.The potential gastrointestinal and other side effects from the weight-loss drugs, which in the U.S. have prompted multiple lawsuits against GLP-1 makers, give some patients pause, Gulati said. But others “are OK with continuing it throughout their life because they know that they won’t be able to control themselves.”A handbook about managing diabetes at a clinic in New Delhi.Saumya Khandelwal for NBC NewsDiabetic patients such as Moinak Pal, who has high insulin resistance, say that GLP-1 drugs have been the easiest way to lose weight.“I have been fat-shamed since I was a child,” said Pal, 34, a Noida-based journalist. He said he has been losing about 3 pounds a week since he started taking Mounjaro.It was “extremely difficult for me to lose weight by conventional means,” he said.Part of the problem, Misra said, is the lifestyle in India’s sprawling and congested urban areas, where commutes can last as long as four hours round-trip. When workers get home, apps can deliver everything from food to clothes to their doorsteps in minutes.“They want quick fixes that don’t involve going on a restrictive diet or daily exercise of an hour and so on,” he said of some of his patients. “As a result, diabetes is everywhere. Every day I see patients who are young, who have uncontrolled Type 2 diabetes.”Rajendra Nath Dixit blames nobody but himself for his health problems. The retired banker had heart bypass surgery earlier this year, and before that had been spending almost 8,000 rupees ($90) a month just on his insulin.“I was fond of taking the typical Indian oily foods, samosas, chole bhature, and in the evening I would take five or six rotis,” said Dixit, 66. “Every bad habit was there.”In the five months since his surgery, Dixit has switched over completely to the oral semaglutide Rybelsus, is exercising more and is consuming less fat and sugar. He is spending 11,000 rupees ($125) a month on Rybelsus, but has been able to stop using insulin.“I’m feeling very good, very light,” he said. “My confidence has gone up, and my life has totally changed.”Mithil AggarwalMithil Aggarwal is a Hong Kong-based reporter/producer for NBC News.
November 13, 2025
Rubio dismisses concerns about strikes at G7 meeting
Comments are closed.
Scroll To Top
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics
© Copyright 2025 - Be That ! . All Rights Reserved